Impact of body mass on hospital resource use in total hip arthroplasty

被引:29
作者
Batsis, John A. [1 ]
Naessens, James M. [2 ]
Keegan, Mark T. [3 ]
Wagie, Amy E. [2 ]
Huddleston, Paul M. [4 ]
Huddleston, Jeanne M. [2 ,5 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Dept Med, Gen Internal Med Sect, Lebanon, NH 03756 USA
[2] Mayo Clin, Coll Med, Div Hlth Care Policy & Res, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Anesthesia, Rochester, MN USA
[4] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA
[5] Mayo Clin, Coll Med, Dept Med, Div Hosp Med, Rochester, MN USA
关键词
Arthroplasty; Obesity; Costs; Resource utilization; HEALTH-CARE COSTS; UNITED-STATES; RISK-FACTORS; CARDIOVASCULAR-DISEASE; MEDICAL EXPENDITURES; OBESE-PATIENTS; TRENDS; INDEX; PREVALENCE; OUTCOMES;
D O I
10.1017/S1368980009005072
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To determine the impact of BMI on post-operative outcomes and resource utilization following elective total hip arthroplasty (THA). Design: A retrospective cohort analysis on all primary elective THA patients between 1996 and 2004. Primary outcomes investigated using regression analyses included length of stay (LOS) and costs (US dollars). Setting: Mayo Clinic Rochester, a tertiary care centre. Subjects: Patients were stratified by pre-operative BMI as normal (18.5-24.9 kg/m(2) overweight (25.0-29.9 kg/m(2)), obese (30.0-34.9 kg/m(2)) and morbidly obese ( >= 35.0 kg/m(2)). Of 5642 patients, 1362 (24.1%) patients had a normal BMI, 2146 (38.0%) were overweight, 1342 (23.8%) were obese and 792 (14.0%) were morbidly obese. Results: Adjusted LOS was similar among normal (4.99d), overweight (5.00d), obese (5.02 d) and morbidly obese (5.17 d) patients (P = 0.20). Adjusted overall episode costs were no different (P=0.23) between the groups of normal ($17 211), overweight ($17462), obese ($17 195) and morbidly obese ($17 655) patients. Overall operative and anaesthesia costs were higher in the morbidly obese group ($5688) than in normal ($5553), overweight ($5549) and obese ($5593) patients (P = 0.03). Operating room costs were higher in morbidly obese patients ($3418) than in normal ($3276), overweight ($3291) and obese ($3340) patients (P<0.001). Post-operative costs were no different (P=0.30). Blood bank costs differed (P=0.002) and were lower in the morbidly obese group ($180) compared with the other patient groups (P<0.05). Other differences in costs were not significant. Morbidly obese patients were more likely to be transferred to a nursing home (24.1%) than normal (18.4%), overweight (17.9%) or obese (16.0%) patients (P=0.001 each). There were no differences in the composite endpoint of 30d mortality, re-admissions, re-operations or intensive care unit utilization. Conclusions: BMI in patients undergoing primary elective THA did not impact LOS or overall institutional acute care costs, despite higher operative costs in morbidly obese patients. Obesity does not increase resource utilization for elective THA.
引用
收藏
页码:1122 / 1132
页数:11
相关论文
共 51 条
  • [1] Moderate and severe obesity have large differences in health care costs
    Andreyeva, T
    Sturm, R
    Ringel, JS
    [J]. OBESITY RESEARCH, 2004, 12 (12): : 1936 - 1943
  • [2] [Anonymous], 2002, DIABETES CARE, V26, P917
  • [3] Batsis John A, 2009, Am J Orthop (Belle Mead NJ), V38, pE5
  • [4] Berry DJ, 1997, CLIN ORTHOP RELAT R, P61
  • [5] Projecting the need for hip replacement over the next three decades: influence of changing demography and threshold for surgery
    Birrell, F
    Johnell, O
    Silman, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (09) : 569 - 572
  • [6] Bowditch MG, 1999, ANN ROY COLL SURG, V81, P198
  • [7] Hospital resource utilization for primary and revision total hip arthroplasty
    Bozic, KJ
    Katz, P
    Cisternas, M
    Ono, L
    Ries, MD
    Showstack, J
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (03) : 570 - 576
  • [8] A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip
    Chang, RW
    Pellissier, JM
    Hazen, GB
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11): : 858 - 865
  • [9] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [10] DeFrances Carol J, 2004, Adv Data, P1